CLSA Events

Life Science Series: Fundraising in Troubled Times

Life Science Series: Fundraising in Troubled Times:
Alternatives to the Traditional Forms of Funding

In collaboration with
Burr Pilger Mayer

For life science companies facing lengthy, high-cost R&D cycles, government approvals, and difficult clinical trials, funding is their lifeblood. Of course, there’s less money to go around these days with the IPO market essentially having grinded to a halt and the competition for VC funding fierce. Fortunately, there are other sources.

This panel discussion will cover some of the lesser-known funding options available in today’s marketplace. Accounting, finance, and legal considerations surrounding these alternatives will be discussed in detail. In addition, experts working at venture capital and Super Angel firms, to provide their perspectives and insights.

The following areas will be addressed:

  • Private Investments in Public Securities (PIPEs)
  • Reverse mergers
  • Super Angel funding
  • Smaller venture capital rounds
  • Foreign investor financings
  • Federal government grants


Michael Benjamin 
Shareholder, Burr Pilger Mayer, Inc.


Larry Gerrans
President & CEO, Sanovas

Jerry Iwata
Vice President, Wells Fargo Bank

Bruce W. Jenett
Partner and Co-Chair, Global Life Sciences Sector DLA Piper

Michael Powell, PhD
General Partner, Sofinnova Ventures

Kim Tsuchimoto 
Chief Financial Officer, Treasurer and Secretary Raptor Pharmaceutical Corporation

What: Life Science Series: Fundraising in Troubled Times: Alternatives to the Traditional Forms of Funding
When: Thursday, January 26, 2012
Registration: 8:00AM – 9:00AM
Breakfast, Networking: 8:00AM – 8:30AM
Program: 8:30AM – 9:30AM
Networking: 9:30AM – 10:30AM
Where: DLA Piper
2000 University Avenue
East Palo Alto, California 94303
Cost: This Event is Sold Out
Attire: Business attire suggested